je.st
news
Roswell Park Cancer Institute, Jasco Pharmaceuticals Join Forces To Advance Drug Research
2013-05-31 12:50:00| drugdiscoveryonline News Articles
A new partnership, first of its kind for both organizations, will see Roswell Park Cancer Institute (RPCI) and Jasco Pharmaceuticals, LLC collaborating to advance development of an investigational pharmacological therapy that shows promise for treating both solid-tumor cancers and hematologic malignancies
Tags: join
research
park
institute
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|